Robot-assisted radical prostatectomy and robot-assisted simple prostatectomy are minimally invasive procedures associated with reduced postoperative pain compared to open surgery. However, effective postoperative analgesia remains crucial to optimize recovery, reduce opioid consumption, minimize postoperative nausea and vomiting (PONV), and support early mobilization within Enhanced Recovery After Surgery (ERAS) pathways. Several loco-regional analgesic techniques have been proposed as alternatives to epidural analgesia, including thoracic Erector Spinae Plane Block (ESPB), Rectus Sheath Block (RSB), and low-dose intrathecal (spinal) analgesia. These techniques differ in their mechanisms of action, invasiveness, and potential impact on somatic and visceral pain control. This prospective, randomized, single-center study aims to compare the analgesic efficacy and postoperative recovery profiles of three loco-regional analgesic strategies in patients undergoing robot-assisted radical prostatectomy or robot-assisted simple prostatectomy. A total of 147 patients will be randomized to receive thoracic ESPB, bilateral RSB or low-dose spinal analgesia, in combination with standardized general anesthesia according to institutional ERAS protocols. Primary outcome is postoperative pain assessed using the Numerical Rating Scale (NRS). Secondary outcomes include opioid and antiemetic rescue requirements, incidence of PONV, time to recovery of oral intake and mobilization, length of hospital stay, and short- and medium-term postoperative complications, with follow-up up to 30 days after surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
147
This technique aims to provide both somatic and visceral analgesia through paravertebral spread of local anesthetic, potentially improving control of abdominal and pelvic pain while reducing opioid consumption and opioid-related side effects.
The RSB primarily targets anterior abdominal wall pain, particularly at laparoscopic port sites, and is intended to reduce postoperative parietal pain and opioid requirements while maintaining a favorable safety profile.
This approach provides rapid and effective analgesia with a strong opioid-sparing effect and is commonly used to optimize early postoperative pain control, while carefully monitoring for opioid-related adverse effects.
Galliera Hospital
Genova, Ge, Italy
Postoperative Pain Intensity
Postoperative pain will be assessed using the Numerical Rating Scale (NRS), from 0 to 10, where 0 is no pain and 10 is maximum pain. The outcome evaluates the effectiveness of the different loco-regional analgesic techniques in controlling postoperative pain following robot-assisted radical prostatectomy or robot-assisted simple prostatectomy.
Time frame: From postoperative day 0 (day of surgery) to postoperative day 3 (G0-G3), assessed three times daily.
number of Postoperative Rescue analgesics
Number of rescue analgesics requested per day (n)
Time frame: In-hospital assessment from postoperative day 0 to postoperative day 3 (G0-G3)
incidence of Postoperative nausea and vomiting
Incidence of postoperative nausea and vomiting (PONV), using a NRS scale from 0 to 10, where 0 is no nausea and 10 is vomiting \> 3 times/die
Time frame: In-hospital assessment from postoperative day 0 to postoperative day 3 (G0-G3)
recovery after surgery
* Day to recovery of oral intake (n) * Day to first mobilization (n) These outcomes aim to evaluate the overall impact of each analgesic strategy on recovery quality, safety, and adherence to ERAS principles.
Time frame: In-hospital assessment from postoperative day 0 to discharge
In-hospital length of stay
Length of hospital stay (n. days)
Time frame: day of discharge (up to 30 days)
Complications
Occurrence of short- and medium-term postoperative complications (Clavien-Dindo classification from Grade I to Grade V)
Time frame: In-hospital assessment at discharge and Follow-up assessment at 30 days after surgery (telephone interview)
Type of rescue analgesic given
Type of rescue analgesic administered (NSAIs, acetaminophen, opioid)
Time frame: In-hospital assessment from postoperative day 0 to postoperative day 3 (G0-G3)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.